Literature DB >> 24648378

Conditional Monte Carlo randomization tests for regression models.

Parwen Parhat1, William F Rosenberger, Guoqing Diao.   

Abstract

We discuss the computation of randomization tests for clinical trials of two treatments when the primary outcome is based on a regression model. We begin by revisiting the seminal paper of Gail, Tan, and Piantadosi (1988), and then describe a method based on Monte Carlo generation of randomization sequences. The tests based on this Monte Carlo procedure are design based, in that they incorporate the particular randomization procedure used. We discuss permuted block designs, complete randomization, and biased coin designs. We also use a new technique by Plamadeala and Rosenberger (2012) for simple computation of conditional randomization tests. Like Gail, Tan, and Piantadosi, we focus on residuals from generalized linear models and martingale residuals from survival models. Such techniques do not apply to longitudinal data analysis, and we introduce a method for computation of randomization tests based on the predicted rate of change from a generalized linear mixed model when outcomes are longitudinal. We show, by simulation, that these randomization tests preserve the size and power well under model misspecification.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  generalized linear mixed models; generalized linear models; linear rank test; longitudinal data; martingale residuals; time-to-event data

Mesh:

Year:  2014        PMID: 24648378      PMCID: PMC4109830          DOI: 10.1002/sim.6149

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Pros and cons of permutation tests in clinical trials.

Authors:  V W Berger
Journal:  Stat Med       Date:  2000-05-30       Impact factor: 2.373

2.  A randomized, controlled, double-blind study comparing the survival benefit of four different reverse transcriptase inhibitor therapies (three-drug, two-drug, and alternating drug) for the treatment of advanced AIDS. AIDS Clinical Trial Group 193A Study Team.

Authors:  K Henry; A Erice; C Tierney; H H Balfour; M A Fischl; A Kmack; S H Liou; A Kenton; M S Hirsch; J Phair; A Martinez; J O Kahn
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998-12-01
  2 in total
  3 in total

1.  Assessing intervention effects in a randomized trial within a social network.

Authors:  Shaina J Alexandria; Michael G Hudgens; Allison E Aiello
Journal:  Biometrics       Date:  2021-11-26       Impact factor: 1.701

2.  Autoregressive transitional ordinal model to test for treatment effect in neurological trials with complex endpoints.

Authors:  Lorenzo G Tanadini; John D Steeves; Armin Curt; Torsten Hothorn
Journal:  BMC Med Res Methodol       Date:  2016-11-08       Impact factor: 4.615

3.  Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes.

Authors:  Muriel Buri; Armin Curt; John Steeves; Torsten Hothorn
Journal:  BMC Med Res Methodol       Date:  2020-05-06       Impact factor: 4.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.